All Stories

  1. Selective anticancer copper(ii)-mixed ligand complexes: targeting of ROS and proteasomes
  2. Ternary copper(ii)-polypyridyl enantiomers: aldol-type condensation, characterization, DNA-binding recognition, BSA-binding and anticancer property